Literature DB >> 15010055

Vagus nerve stimulation for refractory idiopathic generalised epilepsy.

Michael Ng1, Orrin Devinsky.   

Abstract

We reviewed our experience with vagus nerve stimulation (VNS) in 165 patients with medically refractory epilepsy (138 partial epilepsy (PE), 13 symptomatic generalised epilepsy (SGE), 14 idiopathic generalised epilepsy (IGE)). Average duration of VNS therapy was 21.6 months. A 50% or greater reduction in seizure frequency was achieved in 47.1% of the PE group, 46.1% of the SGE group, and 57.1% of the IGE group. A 50% or greater reduction in seizure frequency and reduced antiepileptic drug (AED) regimen were achieved in: PE (9.4%), SGE (7.7%), and IGE (35.7%). These preliminary results suggest that VNS is an effective therapy for some patients with medically refractory IGE.

Entities:  

Mesh:

Year:  2004        PMID: 15010055     DOI: 10.1016/S1059-1311(03)00147-X

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  14 in total

1.  Vagus nerve stimulation for generalized epilepsy?...Show me the evidence!

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2008 Mar-Apr       Impact factor: 7.500

Review 2.  Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults.

Authors:  Linda J Stephen; Martin J Brodie
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

3.  When should corpus callosotomy be offered as palliative therapy?

Authors:  Bassel W Abou-Khalil
Journal:  Epilepsy Curr       Date:  2010-01       Impact factor: 7.500

4.  Reduced default mode network connectivity in treatment-resistant idiopathic generalized epilepsy.

Authors:  Benjamin P Kay; Mark W DiFrancesco; Michael D Privitera; Jean Gotman; Scott K Holland; Jerzy P Szaflarski
Journal:  Epilepsia       Date:  2013-01-07       Impact factor: 5.864

Review 5.  Antiepileptic therapy in patients with central nervous system malignancies.

Authors:  Glen H J Stevens
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

6.  Cortical and subcortical contributions to absence seizure onset examined with EEG/fMRI.

Authors:  Jerzy P Szaflarski; Mark DiFrancesco; Thomas Hirschauer; Christi Banks; Michael D Privitera; Jean Gotman; Scott K Holland
Journal:  Epilepsy Behav       Date:  2010-06-26       Impact factor: 2.937

7.  Seizure control in patients with idiopathic generalized epilepsies: EEG determinants of medication response.

Authors:  Jerzy P Szaflarski; Christopher J Lindsell; Tarek Zakaria; Christi Banks; Michael D Privitera
Journal:  Epilepsy Behav       Date:  2010-03-12       Impact factor: 2.937

8.  Long-term results of vagus nerve stimulation in children and adolescents with drug-resistant epilepsy.

Authors:  Beata Majkowska-Zwolińska; Piotr Zwoliński; Marcin Roszkowski; Krzysztof Drabik
Journal:  Childs Nerv Syst       Date:  2012-01-06       Impact factor: 1.475

Review 9.  Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: focus on once-daily lamotrigine.

Authors:  Linda Steinbaugh; Jerzy P Szaflarski
Journal:  Drug Des Devel Ther       Date:  2010-11-18       Impact factor: 4.162

10.  High-frequency burst vagal nerve simulation therapy in a natural primate model of genetic generalized epilepsy.

Authors:  C Á Szabó; F S Salinas; A M Papanastassiou; J Begnaud; M Ravan; K S Eggleston; R Shade; C Lutz; M De La Garza
Journal:  Epilepsy Res       Date:  2017-10-12       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.